For anyone who already has nutrition tracking handled elsewhere and just wants a reliable, well-designed tool for the injection side of their GLP-1 journey, Shotsy is the obvious choice
The medication is effective for weight management, cardiovascular risk reduction, non-alcoholic fatty liver disease, osteoarthritis, and obstructive sleep apnea (OSA) related to obesity and overweight
A total of 478 patients were randomized into equally sized four study arms
For example, one early protocol for substance uses disorders employed 500-1,000 mg of NAD+ per day delivered by slow intravenous infusion over several consecutive days
In these subgroup analyses, oral semaglutide 14 mg or flexibly dosed was more effective at reducing HbA 1c and body weight than the DPP4i sitagliptin when added to a variety of representative background regimens
Patients who maintain or build muscle during GLP-1 treatment experience less metabolic slowdown and better weight maintenance after stopping